Biotech

All Articles

GSK's long-acting asthma medication halved strikes in stage 3

.GSK's long-acting asthma treatment has been actually shown to cut in half the number of attacks in ...

AstraZeneca, Daiichi unpack Dato-DXd's general survival fall short

.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually sto...

Roivant reveals brand-new 'vant' to advance Bayer hypertension med

.Matt Gline is actually back along with a new 'vant' provider, after the Roivant Sciences chief exec...

Viridian eye illness period 3 hits, evolving push to rivalrous Amgen

.Viridian Therapies' period 3 thyroid eye disease (TED) medical trial has reached its own major and ...

Bain introduces $3B fund for life scientific research firms

.With a sturdy performance history for pinpointing diamonds in the rough, Bain Resources Life Scienc...

Genentech's cancer restructure made 'for medical explanations'

.The recent decision to merge Genentech's two cancer cells teams was actually produced "scientific f...

Tern dental GLP-1 reveals 5% fat burning at 1 month at highest dosage

.Terns Pharmaceuticals' selection to fall its liver disease passions may however pay off, after the ...

Merck, Daiichi repeat early effectiveness in tiny cell bronchi cancer along with upgraded ADC information

.Merck &amp Co.'s long-running effort to land a punch on tiny cell lung cancer cells (SCLC) has actu...

Boehringer, Bayer advancement lung cancer cells drugs toward Astra war

.Some patients along with non-small cell bronchi cancer (NSCLC) have anomalies in a genetics named i...

MBX aims for $136M IPO to take rival to Ascendis right into period 3

.MBX has fleshed out programs to take in over $136 million from its own IPO as the biotech hopes to ...